Results for tag: "Bone Metastasis Drug"

The Bone Metastasis Drug market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Bone metastasis is a common complication of cancer, and is the spread of cancer cells to the bones. Bone metastasis drugs are used to reduce pain, prevent fractures, and slow the spread of cancer cells. These drugs are typically administered intravenously or orally, and may include bisphosphonates, denosumab, and radium-223. The Bone Metastasis Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Amgen, Novartis, Merck, Pfizer, and Eli Lilly. Other companies in the market include Sanofi, AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more